What are the recommended dosages and dosing frequencies for the medications used to manage chronic stable angina?

Recommended Dosages and Frequencies for Chronic Stable Angina Medications

Start with a beta-blocker (bisoprolol 10 mg once daily, metoprolol CR 200 mg once daily, or atenolol 100 mg daily) combined with sublingual nitroglycerin 0.4 mg as needed, and if symptoms persist, add a long-acting dihydropyridine calcium channel blocker (amlodipine 5–10 mg once daily). 1

First-Line Antianginal Therapy

Beta-Blockers (Preferred Initial Therapy)

• Bisoprolol: 10 mg once daily 1
• Metoprolol CR: 200 mg once daily 1
• Atenolol: 100 mg once daily 1
• Beta-blockers are recommended as first-line antianginal agents for most patients with chronic coronary syndrome 2, 1

Immediate Symptom Relief

• Sublingual nitroglycerin: 0.4 mg (tablet or spray) as needed for immediate relief and prophylaxis before trigger activities 2, 1
• All patients should be provided with short-acting nitrates regardless of other medications 2

Second-Line: Calcium Channel Blockers

When Beta-Blockers Are Contraindicated or Not Tolerated

• Verapamil (non-dihydropyridine): 240–480 mg once daily 1
• Diltiazem (non-dihydropyridine): 120–360 mg once daily 1
• Non-dihydropyridine CCBs are preferred as monotherapy when beta-blockers cannot be used 1

For Combination Therapy with Beta-Blockers

• Amlodipine (dihydropyridine): 5–10 mg once daily 1, 3
• The combination of a beta-blocker with a dihydropyridine CCB should be considered if symptoms are not controlled by beta-blocker monotherapy 2, 1

Critical Pitfall: Immediate-release short-acting dihydropyridines (e.g., nifedipine) must never be used without concurrent beta-blockade because they increase adverse outcomes 1

Third-Line Add-On Therapy for Refractory Symptoms

Long-Acting Nitrates

• Isosorbide mononitrate: 20 mg twice daily at 8 AM and 3 PM (asymmetrical dosing) 4
• Requires a 10–14 hour nitrate-free interval daily to prevent tolerance 2, 1, 4
• This asymmetrical dosing provides at least 12 hours of antianginal coverage without tolerance development 4

Ranolazine

• Ranolazine: 500 mg twice daily or 1000 mg once daily 5
• Should be considered as add-on therapy when symptoms persist on beta-blockers and/or CCBs 2
• Demonstrated efficacy as add-on to metoprolol in reducing weekly anginal frequency 5

Ivabradine (For Specific Populations)

• Ivabradine: 5 mg twice daily or 7.5 mg twice daily 6
• Should be considered as add-on therapy in patients with left ventricular systolic dysfunction (LVEF <40%) and inadequate symptom control 2
• Not recommended as add-on therapy in patients with LVEF >40% and no clinical heart failure 2
• Contraindicated in combination with non-dihydropyridine CCBs or strong CYP3A4 inhibitors 2

Nicorandil or Trimetazidine

• May be considered as add-on therapy when symptoms remain inadequately controlled on beta-blockers and/or CCBs 2

Essential Concomitant Medications

Antiplatelet Therapy

• Aspirin: 75–325 mg once daily, started promptly and continued indefinitely unless contraindicated 1
• Clopidogrel: Replaces aspirin only in patients with documented aspirin hypersensitivity or major gastrointestinal intolerance 1

Statin Therapy

• Should be initiated in all patients with chronic coronary syndrome regardless of baseline cholesterol 1
• Reduces mortality and ischemic events 1

ACE Inhibitor Therapy

• Should be started in all patients with chronic coronary syndrome, especially those with hypertension, diabetes, left ventricular dysfunction, or heart failure 1

Critical Contraindications and Drug Interactions

Nitrate-Related

• Nitrates must be avoided within 24 hours of sildenafil use due to risk of severe hypotension 1
• Nitrates are not recommended in patients with hypertrophic cardiomyopathy or in co-administration with phosphodiesterase inhibitors 2

Beta-Blocker Precautions

• Use cautiously in patients with severe bradycardia (<50 bpm), high-grade AV block, or severe asthma/COPD 1
• If discontinuation is necessary, taper over four weeks to prevent rebound ischemia 1

Calcium Channel Blocker Interactions

• Co-administration of non-dihydropyridine CCBs and beta-blockers may cause excessive bradycardia or heart block in predisposed patients 1

Treatment Algorithm

1. Initiate beta-blocker monotherapy at target doses (bisoprolol 10 mg, metoprolol CR 200 mg, or atenolol 100 mg daily) plus sublingual nitroglycerin as needed 2, 1

2. If symptoms persist: Add long-acting dihydropyridine CCB (amlodipine 5–10 mg daily) 2, 1

3. If symptoms still inadequate: Add long-acting nitrates (isosorbide mononitrate 20 mg twice daily with asymmetrical dosing) OR ranolazine (500 mg twice daily or 1000 mg once daily) 2, 1, 5, 4

4. For patients with LVEF <40%: Consider ivabradine (5–7.5 mg twice daily) as add-on therapy 2, 6

5. If beta-blockers contraindicated: Use non-dihydropyridine CCB monotherapy (verapamil 240–480 mg or diltiazem 120–360 mg daily) 1

The selection of antianginal drugs should be tailored to patient characteristics, comorbidities, concomitant medications, treatment tolerability, and underlying pathophysiology of angina 2